514 Episodes

  1. S7 Ep1: Karmanos Faculty Share Experiences and Career Insights as Women in Oncology

    Published: 5/30/2022

  2. S6 Ep50: Tarantino Previews Exciting Research in HER2-Low Breast Cancer

    Published: 5/26/2022

  3. S6 Ep49: Taylor Provides Insight Into Pirtobrutinib Resistance in CLL

    Published: 5/23/2022

  4. S6 Ep48: Pro Presents Interim Results of PRIMO in Peripheral T-Cell Lymphoma

    Published: 5/19/2022

  5. S6 Ep47: Pal Discusses Eye-Catching ASCO GU Data in RCC

    Published: 5/16/2022

  6. S6 Ep46: Pegram Expounds on Exciting Developments in HER2+ Metastatic Breast Cancer

    Published: 5/12/2022

  7. S6 Ep45: Cusnir on the Benefits of SIR-Spheres® Y-90 Resin Microspheres in mCRC

    Published: 5/9/2022

  8. S6 Ep44: Borgen Recommends Revamping Peer Review for a Post-COVID-19 World

    Published: 5/5/2022

  9. S6 Ep43: FDA Approval Insights: Relatlimab Plus Nivolumab in Melanoma

    Published: 5/2/2022

  10. S6 Ep42: Jabbour Highlights New Data With Asciminib and Ponatinib in CML

    Published: 4/28/2022

  11. S6 Ep41: Bardia Reflects on Important Data in HER2+ Breast Cancer

    Published: 4/21/2022

  12. S6 Ep40: D'Abreo Addresses AEs in Metastatic Breast Cancer Care

    Published: 4/14/2022

  13. S6 Ep39: Tripathy on Treating HER2+ Breast Cancer With Leptomeningeal Metastasis

    Published: 4/7/2022

  14. S6 Ep38: FDA Approval Insights: Pacritinib in Myelofibrosis

    Published: 3/31/2022

  15. S6 Ep37: Research Reflections: Barzi Reviews CRC Updates From ASCO GI 2022

    Published: 3/24/2022

  16. S6 Ep36: Lyle and Patel Examine Diagnostic and Management Paradigms in MDS

    Published: 3/17/2022

  17. S6 Ep35: Ross Reflects on Surgical Advances and Changing Trends in CRC

    Published: 3/10/2022

  18. S6 Ep35: Hurvitz Reviews Pivotal Data From 2021, Previews Year Ahead in HER2+ Metastatic Breast Cancer

    Published: 3/3/2022

  19. S6 Ep34: Jain Talks Patient Management, Dosing, and Toxicity Mitigation With Frontline PARP Maintenance in Ovarian Cancer

    Published: 2/24/2022

  20. S6 Ep28: Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1

    Published: 2/17/2022

22 / 26